A group of 135 patients was investigated, who suffered from Hodgkin's disease with long-term remission following radiotherapy. By restricting the investigations to the patient group with long-term remission and correlative examinations, differentiation was made between exclusive or principal delayed radiation effects and delayed effects due to other factors. The study reports the most significant results obtained in the fields of catamnesis, laboratory diagnostics, hematology, pulmology, cardiology, thyroid function tests, neurology, andrology and dermatology. Due to the numerous detectable delayed effects the group of patients with long-term remission receives a special status. Although those effects are in no proportion to the deletary risks of an untreated Hodgkin's disease and though they are consequently tolerable in the present state of the therapeutic development, they must initiate the completion of the therapeutic concept including performance of radiotherapy and aftercare, because only then the risk for the patient provoked by these effects, which ranges beyond the malignity of this disease can be reduced or prevented.